Copyright
©The Author(s) 2018.
World J Gastroenterol. Sep 28, 2018; 24(36): 4104-4118
Published online Sep 28, 2018. doi: 10.3748/wjg.v24.i36.4104
Published online Sep 28, 2018. doi: 10.3748/wjg.v24.i36.4104
Table 1 MicroRNA targets involved in alcoholic liver disease pathogenesis
| miRNA | Source of sample | miRNA target |
| let-7[27] | Animal models | Lin28, HMGA2 |
| Human HSCs | ||
| miR-19b[28] | Animal models | TGFβRII, Col1α2, MeCP2 |
| Human HSCs | ||
| miR-21[36,37] | Animal models | FASLG, DR5, Crebl2 |
| miR-26a[35] | Animal models | DUSP4, DUSP5 |
| miR-27a[44,52] | Animal models | Sprouty2, CD206 |
| HMC | ||
| Humans (plasma) | ||
| miR-34a[29,43] | Animal models | SIRT1, CASP2 |
| Human HSCs | ||
| NHH | ||
| HiBECs | ||
| Humans (liver biopsy) | ||
| miR-103 and miR-107[53] | Humans (liver biopsy) | Caveolin-1 |
| miR-122[32,124,125] | Animal models | P4HA1, HO-1, Cyclin G1, Bcl-w, HIF-1α |
| miR-155[38,39,97,126,127] | Animal models | TNFα, SHIP1, SOCS1, IRAKM, C/EBPβ |
| miR-181b-3p[40] | Animal models | Importin α1 |
| miR-182[30] | Animal models | SLC1A1, Cofilin 1, CCL20, CXCL1, IL-8, Cyclin D1, IL-6 |
| Humans (serum samples and liver biopsy) | ||
| miR-199[128] | Animal models | ET-1, ET-BR |
| miR-200a[31] | Animal models | ZEB-2 |
| miR-212[46] | Caco-2 cells | ZO-1 |
| Humans (colon biopsy) | ||
| miR-214[24,34] | Animal models | POR, GSR, CYP2E1 |
| HHCs | ||
| miR-217[41] | Animal models | SIRT-1 |
| miR-223[45] | Animal models | p47phox, IL-6 |
| Humans (serum) | ||
| miR-291b[42] | Animal models | Tollip |
| HPBMs | ||
| miR-378[59] | Animal models | Gli-3 |
| miR-497[25] | Animal models | Btg2, Yy1 |
Table 2 Summary of microRNAs associated with non-alcoholic fatty liver disease
| miRNA | Source of samples | Change | Main targets |
| miR-9[129] | Human serum; | Upregulated | Onecut2; SIRT1 |
| Human hepatocyte cell line | |||
| miR-10b[130] | Human hepatocyte cell line | Downregulated | PPARα |
| miR-15b[131,132] | Animal models | Upregulated | |
| Human serum | |||
| miR-16[104] | Human serum | Upregulated | |
| miR-17[74] | Human liver | Downregulated | |
| miR-19[84] | Human serum | Upregulated | |
| miR-21[86,87,99,133-136] | Animal models | Upregulated | PPARα; TGF-β |
| Human hepatocyte cell line | PTEN | ||
| Human liver and serum | |||
| miR-21[85,89,137,138] | Animal models | Downregulated | HMGCR; FABP7 |
| Human liver | |||
| Human hepatocyte cell line | |||
| miR-24[139] | Animal models | Upregulated | Insig1; SREBP |
| Human hepatocyte cell line | |||
| miR-26[140] | Animal models | Downregulated | IL-6, IL-7 |
| miR-27a[141] | Animal models | Downregulated | |
| miR-27b[102] | Human serum | Upregulated | |
| miR-29a[142,143] | Animal models | Downregulated | HMGCR; LPL |
| miR-29c[85,89,90] | Animal models | Downregulated | DNMT3A; DNMT3B |
| miR-30b[83] | Human liver | Downregulated | ITGAX; FABP4 |
| Human hepatocyte cell line | |||
| miR-30c[144] | Human serum | Upregulated | |
| miR-31[74,89] | Human liver | Upregulated | |
| Animal models | |||
| miR-33a[73,76] | Human liver | Upregulated | ABCA1; ABCA2 |
| miR-33a[85] | Human liver | Downregulated | |
| MiR-34a[71,81,82,85,87,89,90,92,104,105,145-148] | Animal models | Upregulated | SIRT1; HNF4α; PPARα |
| Human hepatocyte cell line | |||
| Human liver and serum | |||
| miR-99a[149] | Human serum | Downregulated | |
| miR-101[150] | Human hepatocyte cell line | Upregulated | ABCA1 |
| Human monocyte cell line | |||
| miR-103[53,89,151] | Animal models | Upregulated | Cav1 |
| Human liver and serum | |||
| miR-103a[152] | Human liver | Upregulated | |
| Human hepatocyte cell line | |||
| miR-106b[152] | Human liver | Upregulated | |
| miR-107[53,89] | Animal models | Upregulated | Cav1 |
| Human liver | |||
| miR-122[81,84,86,87,101-104,106,153] | Animal models | Upregulated | |
| Human Serum | |||
| miR-122[71,82-85,89,90,99,106,141,154,155] | Animal models | Downregulated | ACC-2; HAMP; FAS; HMGCR; SREBF-1c |
| Human liver | SREPBF-2; HIF-1α; Vimentin; MAP3K3 | ||
| miR-125b[84] | Human serum | Upregulated | |
| miR-125b[156] | Animal models | Downregulated | FAS |
| miR-139-5p[83] | Human liver | Downregulated | TNFα |
| miR-144[76] | Human Liver | Upregulated | ABCA1 |
| miR-144[157] | Animal models | Downregulated | TLR-2 |
| miR-146a[158] | Animal models | Upregulated | |
| Human hepatocyte cell line | |||
| miR-146a[132] | Animal models | Downregulated | Wnt1; Wnt5 |
| Human hepatocyte cell line | |||
| Mir-146b[149,159] | Animal models | Downregulated | IRAK1 |
| Human serum | TRAF6 | ||
| Human hepatocyte cell line | |||
| miR-146b[71,83,158] | Animal models | Upregulated | |
| Human liver | |||
| Human hepatocyte cell line | |||
| miR-149[160] | Animal models | Upregulated | FGF-21 |
| Human hepatocyte cell line | |||
| miR-150[74] | Human liver | Upregulated | |
| miR-152[158] | Animal models | Upregulated | |
| Human hepatocyte cell line | |||
| miR-155[90,97-99,161,162] | Animal models | Upregulated | SOCS1; C/EBP-Β; CES3; PDGF; SMAD3 |
| Human hepatocyte cell line | |||
| miR-155[96] | Animal models | Downregulated | LXRα |
| Human liver and serum | |||
| miR-181a[82] | Animal models | Upregulated | |
| miR-181d[149] | Human serum | Downregulated | |
| miR-182[74] | Human liver | Upregulated | FOXO3 |
| miR-183[74] | Human liver | Upregulated | |
| miR-192[84,90] | Animal models | Downregulated | |
| Human liver | |||
| miR-192-5p[82,84,86,102,106] | Animal models | Upregulated | |
| Human liver and serum | |||
| miR-194[89] | Animal models | Upregulated | |
| miR-197[149] | Human serum | Downregulated | |
| miR-199[163] | Animal models | Upregulated | Cav1; PPARα |
| Human hepatocyte cell line | |||
| Human liver | |||
| miR-200a/b/c[74,82,89,90,141,158,162,164] | Animal models | Upregulated | ZEB1; CDH1; EZH2; IRP1 |
| Human hepatocyte cell line | |||
| miR-203[90,132] | Animal models | Downregulated | |
| miR-212[165] | Animal models | Upregulated | FGF-21 |
| Human hepatocyte cell line | |||
| miR-214[71,166] | Human liver | Upregulated | |
| Animal models | |||
| miR-216[167] | Animal models | Downregulated | |
| miR-219a[74] | Human liver | Downregulated | |
| miR-221[73] | Human liver | Downregulated | |
| miR-221[89,90,99] | Animal models | Upregulated | |
| miR-222[99] | Animal models | Upregulated | |
| miR-223[86,164] | Animals models | Upregulated | IRP1 |
| Human serum | |||
| miR-224[73,74] | Human liver | Upregulated | |
| miR-291b[168] | Animal models | Upregulated | AMPKα1 |
| miR-302a[167] | Animals model | Downregulated | ELOVL6 |
| miR-331[144] | Human serum | Upregulated | |
| miR-335[89] | Animal models | Upregulated | |
| miR-375[84] | Human serum | Upregulated | |
| miR-378i[74] | Human liver | Downregulated | |
| miR-421[169] | Animal models | Upregulated | SIRT-3 |
| miR-422a[83] | Human liver | Downregulated | |
| miR-429[141] | Animal models | Upregulated | |
| miR-451[87] | Human Serum | Upregulated | |
| miR-451[89,141,170] | Animal models | Downregulated | AMPK/AKT |
| Human liver | |||
| miR-467b[171] | Animal models | Downregulated | LPL |
| miR-576[152] | Human liver | Downregulated | RAC1 |
| Human hepatocyte cell line | |||
| miR-590[74] | Human liver | Downregulated | |
| miR-892a[152] | Human liver | Upregulated | |
| Human hepatocyte cell line | |||
| miR-1290[102] | Human serum | Upregulated |
- Citation: Torres JL, Novo-Veleiro I, Manzanedo L, Alvela-Suárez L, Macías R, Laso FJ, Marcos M. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(36): 4104-4118
- URL: https://www.wjgnet.com/1007-9327/full/v24/i36/4104.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i36.4104
